DNA Hepatitis B Vaccine Promising in Nonresponders to Licensed Vaccines

xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> DNA Hepatitis B Vaccine Promising in Nonresponders to Licensed Vaccines

DNA HEPATITIS B VACCINE PROMISING IN NONRESPONDERS TO LICENSED VACCINES


A new DNA hepatitis B vaccine appears safe and immunogenic in patients
nonresponsive to licensed hepatitis B vaccines, according to the
findings of a study presented Tuesday at the Fourth Annual Conference on
Vaccine Research.


http://id.medscape.com/37030.rhtml?srcmp=id-042701
<a href="http://id.medscape.com/37030.rhtml?srcmp=id-042701"> Read it
Here</a>

As many as 50% of people over the age of 60 don't respond to licensed
hepatitis B vaccines," Dr. Poland told Reuters Health. "It is also a
problem in HIV patients, diabetics, immunosuppressed patients, obese
individuals, dialysis patients and smokers." When "you put all these groups
together you realize that there are a fair number of people who are not
protected against hepatitis B," he noted


ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.